Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou, Jiangxi, 341000, China.
Department of Neurosurgery, Institute of Brain Disease, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, China.
BMC Pediatr. 2023 Sep 7;23(1):447. doi: 10.1186/s12887-023-04213-9.
Extracranial metastasis can occur in intracranial germ cell tumors (GCTs), but it is very rare. Recurrence or metastasis of non-germinomatous germ cell tumors (NGGCTs) is often accompanied by elevated tumor markers. Occult extracranial metastases or recurrences with negative markers are often difficult to detect in time, resulting in a very poor prognosis.
A 12-year-old boy was admitted to our institution with dizziness, headache, vomiting, and sleepiness. Magnetic resonance imaging (MRI) showed a pineal mass, accompanied by a significant increase in serum alpha-fetoprotein (AFP). The patient subsequently underwent total removal of the tumor. Pathology revealed that the tumor was a mixed GCT, consisting of mature teratoma, germinoma, and yolk sac tumor. Intracranial GCT achieved complete remission after intensive adjuvant chemotherapy and radiotherapy. Regular follow-up MRI revealed no recurrence of the intracranial tumor and continued monitoring of tumor markers revealed no abnormalities. Eight months later, the patient was readmitted due to progressive abdominal pain. Imaging and physical examination revealed abdominal occupation and lymphatic mass in the neck. He received salvage chemotherapy, anti-PD-1 immunotherapy, and palliative chemotherapy, but still developed multiple organ dysfunction syndromes (MODS) due to tumor progression and eventually died after one month.
This profound case suggests that intracranial NGGCTs may develop occult extracranial malignancy, which can be very severe at the time of clinical symptoms and has an extremely poor prognosis. Therefore, in addition to tumor marker monitoring, regular follow-up with extracranial imaging may be warranted to detect extracranial tumors as early as possible, although perhaps not as frequently as with neuroimaging.
颅外转移可发生于颅内生殖细胞瘤(GCT)中,但极为罕见。非生殖细胞性生殖细胞瘤(NGGCT)的复发或转移常伴有肿瘤标志物升高。隐匿性颅外转移或标志物阴性的复发往往难以及时发现,导致预后极差。
一名 12 岁男孩因头晕、头痛、呕吐和嗜睡而入院。磁共振成像(MRI)显示松果体肿块,伴有血清甲胎蛋白(AFP)显著升高。随后,患者接受了肿瘤的全切除。病理结果显示肿瘤为混合性 GCT,由成熟畸胎瘤、生殖细胞瘤和卵黄囊瘤组成。颅内 GCT 在强化辅助化疗和放疗后达到完全缓解。定期行 MRI 随访未见颅内肿瘤复发,肿瘤标志物持续监测未见异常。8 个月后,患者因进行性腹痛再次入院。影像学和体格检查显示腹部占位和颈部淋巴结肿大。他接受了挽救性化疗、抗 PD-1 免疫治疗和姑息性化疗,但仍因肿瘤进展而发生多器官功能障碍综合征(MODS),最终在一个月后死亡。
这个深刻的病例提示,颅内 NGGCT 可能发生隐匿性颅外恶性肿瘤,其在出现临床症状时可能非常严重,且预后极差。因此,除了肿瘤标志物监测外,可能需要定期进行颅外影像学随访,以尽早发现颅外肿瘤,尽管神经影像学检查的频率可能不如后者。